Treatment pathway
Treatment pathway
Treatment using the drainage system follows these steps:
- Catheter implantation
- Patient education
- Safe and effective drainage
The following products are available for draining:
What is it about?
Patients with new-onset pleural effusion or ascites usually have a diagnosed underlying disease causing the effusion.
The course of the underlying disease usually leads to persistent effusion formation. A puncture for therapeutic drainage and collection of material for cytology is later followed by placement of a subcutaneous tunneled catheter for treatment of the effusion.
What do we put up for discussion?
This process can be abbreviated by immediate implantation of a subcutaneously tunneled catheter. During implantation, the effusion can be relieved and at the same time material for cytology can be obtained.
Advantages for you as the treating physician:
- Less time required for treating physician (no repeated punctures and puncture risks)
- Cost reduction DRG
- Forced start of therapy, parallel to drug and / or radiation therapy.
Benefits for your patient:
- No repeated punctures
- Reduction of hospital stays or visits to doctors
- Increase the quality of life and mobility of your patient
Pleural and ascitic catheters
References
- Wahidi, Reddy, Yarmus, et al. Randomized Trial of Pleural Fluid Drainage Frequency in Patients with Malignant Pleural Effusions. The ASAP Trial. American Journal of Respiratory and Critical Care Medicine. 2017; 195(8):1050-1057.
- Reddy, Ernst, Lamb, et al. Rapid pleurodesis for malignant pleural effusions: a pilot study. Chest. 2011; 139(6):1419-1423
- Bhatnagar, Keenan, Morley, et al. Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant Effusion. The New England Journal of Medicine. 2018; 378(14):1313-1322.
- Wong B.C.T et al. Indwelling Peritoneal Catheters for Managing Malignancy-Associated Ascites. J of Palliat Care 2015;243-249
https://www.ncbi.nlm.nih.gov/pubmed/26856125
